Dashenlin Pharmaceutical Group

Dashenlin Pharmaceutical Group is one of the...

• CSI 500.

Dashenlin Pharmaceutical Group is a company listed under the stock ticker 603233 (CN).

View the org chart displaying its 13 main executives

Most searched biographies at Dashenlin Pharmaceutical Group

• Guoqiang Ke, General Manager
• Jinlong Ke, Director
• Guochang Liu, Independent Director

Create your alert
to follow the executive moves at Dashenlin Pharmaceutical Group.

Dashenlin Pharmaceutical Group has 1,867 competitors including Pfizer (United States (USA)), Sanofi (France) and Johnson & Johnson (United States (USA)).

Popular M&A news in Pharmaceuticals

• AstraZeneca has announced the acquisition of Fusion Pharma  (posted on March 23 2024).
• AstraZeneca has announced the acquisition of Amolyt Pharma  (posted on March 19 2024).
• Frontier Medicines has just announced a $80 Million fundraising (posted on February 27 2024).

Popular contacts in Pharmaceuticals

• Jean-Frédéric Paulsen - Executive Chairman of the Board at Ferring Pharmaceuticals
• Alice Schardt-Rossmann - Managing Director at Dirk Rossmann
• Thierry Abribat - Chief Executive Officer at Amolyt Pharma

Learn more about the Pharmaceuticals industry >

Press releases by Dashenlin Pharmaceutical Group

Social media about Dashenlin Pharmaceutical Group

• Dashenlin Pharmaceutical Group on Wikipedia, Google News & Yahoo Finance
• Dashenlin Pharmaceutical Group on LinkedIn, Twitter & YouTube

Call Dashenlin Pharmaceutical Group at +86 208...

View the org chart

Register to receive your alert

Report an error